JournalTOCs

The Lancet Global Health
Journal Prestige (SJR): 8.756

Citation Impact (citeScore): 4
Number of Followers: 74

This is an Open Access Journal

Open Access journal
ISSN (Print) 2214-109X
Published by Elsevier

[2974 journals]

[Editorial] Bringing home manufacturing of medical products
- Authors: The Lancet Global Health
  First page: e796
  Abstract: The pharmaceutical industry has a global health story to tell. Take the R21/Matrix-M malaria vaccine as an example: starting from a laboratory in the UK, it passed a phase 2 trial in Burkina Faso, was approved by authorities in Ghana, was manufactured in India, and will return to Ghana for routine immunisation programmes. Such complexity, as well as the potential fragility and inequity of the global supply chain of medical products such as drugs, vaccines, and diagnostics, was further exposed by COVID-19.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00221-8
  Issue No: Vol. 11, No. 6 (2023)
[Comment] Innovative methods of determining health expenditure efficiency
are urgently needed
- Authors: Zhong Cao; Simiao Chen
  Pages: e797 - e798
  Abstract: Cost-effectiveness thresholds have a crucial role in health economics. They are used by researchers, health-care providers, and policy makers to evaluate the efficiency of health-care spending, prioritise investments, and allocate limited resources. Existing types of cost-effectiveness threshold—arbitrary rules of thumb, demand-side thresholds, and supply-side thresholds—all have drawbacks. Examples of rule-of-thumb cost-effectiveness thresholds include those used in the USA (US$50 000–$100 000 per quality-adjusted life-year [QALY]) and the UK (£20 000–£30 000 per QALY).
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00196-1
  Issue No: Vol. 11, No. 6 (2023)
[Comment] The long reach of war's costs: building the evidence for action
- Authors: Eran Bendavid
  Pages: e799 - e800
  Abstract: Karl Popper's notion of falsification in scientific discovery remains influential nearly 100 years after its formulation.1 The Popperian view of scientific progress posits that theories gain strength by being open to falsification, and at the same time remaining consistent with observed data time and again. This process is how we come to consider scientific theories as representing reality: we posit them in ways that can be empirically confirmed or disconfirmed, we repeatedly test them against observation, and we do not find them false.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00176-6
  Issue No: Vol. 11, No. 6 (2023)
[Comment] Research on high quality health care needs to move beyond what
to how
- Authors: Ashish KC; Peter Waiswa, Mary V Kinney
  Pages: e803 - e804
  Abstract: Health system quality has received much attention since The Lancet Global Health Commission on high quality health systems in 2018, which proposed new ways to define, measure, and improve the performance of health systems.1 Factors influencing quality of health systems are well known, both as inputs and processes, including WHO's six building blocks (service delivery, health workforce, health information systems, access to essential medicines, financing, and leadership and governance),2 but we still need to think how to measure them.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00209-7
  Issue No: Vol. 11, No. 6 (2023)
[Comment] The long view of vaccination to secure the future
- Authors: Karen H Keddy; Luria L Founou
  Pages: e807 - e808
  Abstract: “Whether this distribution of benefits will be attractive to finance ministers depends on many factors”—so state Chloe Puett and colleagues in their analysis of the long-term economic benefits of Shigella vaccination to prevent linear growth faltering (LGF) in The Lancet Global Health.1 The cost of vaccination can be a considerable deterrent in the introduction of a new vaccine, and has contributed to the low coverage rates of rotavirus vaccines and the human papillomavirus (HPV) vaccine, which, where it has been introduced, is only focused on girls and young women,2 despite having been shown to be beneficial in men.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00067-0
  Issue No: Vol. 11, No. 6 (2023)
[Comment] Urine and sputum tuberculosis tests: defining the trade-offs in
endemic HIV and tuberculosis settings
- Authors: Douglas Wilson; Patrick Cudahy, Paul K Drain
  Pages: e809 - e810
  Abstract: Clinicians need improved tests to diagnose tuberculosis, especially in people living with HIV. Sputum-based molecular tests (eg, the Xpert MTB/RIF and Xpert Ultra assays, Cepheid, Sunnyvale, CA, USA) perform well in adults with presumptive tuberculosis who are HIV-positive (ie, sensitivity ≥75% and specificity ≥93%),1 but many patients are unable to produce a quality sputum sample. An alternative biomarker is lipoarabinomannan, a glycolipid from the cell wall of replicating Mycobacterium tuberculosis that enters the bloodstream, is filtered by the kidney, and concentrates in urine.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00215-2
  Issue No: Vol. 11, No. 6 (2023)
[Comment] Halting vaccine-derived poliovirus circulation: the novel type 2
oral vaccine might not be enough
- Authors: Tolbert G Nyenswah; Jessica L Schue
  Pages: e811 - e812
  Abstract: Polio eradication remains elusive, and its progress has been hampered by the COVID-19 pandemic.1 Wild-type polioviruses are endemic in two countries (Afghanistan and Pakistan), but equally concerning is the ongoing spread of circulating vaccine-derived poliovirus type 2 (cVDPV2) several years after the switch to bivalent oral polio vaccine (bOPV).2 The threat of a polio outbreak is greatest for countries with weak public health systems or affected by conflict. Since the transition from trivalent to bivalent OPV in 2016, community transmission of VDPV2 has continued despite the introduction of an inactivated polio vaccine.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00161-4
  Issue No: Vol. 11, No. 6 (2023)
[Comment] Mass drug administration in neglected tropical diseases: beyond
elimination
- Authors: Kaliaperumal Karthikeyan
  Pages: e813 - e814
  Abstract: The impact of neglected tropical diseases on the socioeconomic and social wellbeing of individuals in low-income and middle-income countries is enormous. These neglected tropical diseases account for around 14·5 million disability-adjusted life years, with substantial variation among tropical and non-tropical countries and high-resource and low-resource regions.1 Working in a resource-poor setting and managing these disorders is a challenge for practitioners. Outpatient units are flooded with patients with scabies, helminthiasis, and other neglected tropical diseases.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00213-9
  Issue No: Vol. 11, No. 6 (2023)
[Comment] SARS-CoV-2 in low-income countries: the need for sustained
genomic surveillance
- Authors: Ana S Gonzalez-Reiche
  Pages: e815 - e816
  Abstract: The onset of the COVID-19 pandemic accelerated the implementation of genomic surveillance of its causal agent, SARS-CoV-2, on a global scale. As of April 6, 2023, there were more than 15 million SARS-CoV-2 genomic sequences deposited in the Global Initiative on Sharing Avian Influenza Data database and 6·8 million sequences in GenBank, the two largest virus sequence databases. Despite this unprecedented effort, a pronounced imbalance exists in the extent of SARS-CoV-2 genomic data from high-income and low-income countries.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00197-3
  Issue No: Vol. 11, No. 6 (2023)
[Comment] Reducing the prevalence of smokeless tobacco in an evolving
tobacco landscape
- Authors: Filippos T Filippidis
  Pages: e817 - e818
  Abstract: The global tobacco market is arguably the most diverse it has ever been. Over the past decade, tobacco control policies have led to bans and restrictions of certain types of cigarettes and other tobacco products in some places (eg, menthol cigarettes in the EU and gutka in India). Nevertheless, the tobacco industry has responded by greatly enhancing its portfolio with the introduction of products such as heated tobacco, electronic cigarettes, and flavoured cigarette capsules, which often attract the interest of stakeholders and researchers.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00219-X
  Issue No: Vol. 11, No. 6 (2023)
[Comment] The surge of spreading harmful information through digital
technologies: a distressing reality in complex humanitarian emergencies
- Authors: Dilshad Jaff
  Pages: e821 - e822
  Abstract: Digital technologies, such as social media and artificial intelligence (AI), are increasingly used to spread harmful information during complex humanitarian emergencies. Spreading false or harmful information during emergencies is not new, but the increase in the quantity of harmful information in the last decade is unprecedented.1
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00207-3
  Issue No: Vol. 11, No. 6 (2023)
[Comment] Sustainable Development Goals summit 2023 and the global pledge
on disability-focused early childhood development
- Authors: Bolajoko O Olusanya; Vivian G Cheung, Mijna Hadders-Algra, Cecilia Breinbauer, Tracey Smythe, Marisol Moreno-Angarita, Sally Brinkman, Nihad Almasri, Marta Figueiredo, Olaf Kraus de Camargo, Ike Chinonye Nnanna, Sandra S Block, Claudine Storbeck, Jacob O Olusanya, Brad D Berman, Donald Wertlieb, Andrew N Williams, M K C Nair, Adrian C Davis, Scott M Wright, Global Research on Developmental Disabilities Collaborators
  Pages: e823 - e825
  Abstract: In September, 2023, the second global summit on the Sustainable Development Goals (SDGs) will be held during the annual UN General Assembly for the midpoint appraisal of the 2015–30 Agenda for Sustainable Development.1 The summit will review the global progress in implementing the SDGs, consider new challenges that arose since 2015, provide updated policy guidance, and mobilise action to accelerate progress towards achieving the SDGs. This occasion provides a rare and timely opportunity to review the global commitment on early childhood development (ECD) for children younger than 5 years, and to leave no one behind (SDG 4.2).
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00178-X
  Issue No: Vol. 11, No. 6 (2023)
[Comment] A new precedent in international health cooperation from African
public health leaders
- Authors: Fabian Moser; Mahlet Kifle Habtemariam, Frode Forland, Benjamin Djoudalbaye
  Pages: e828 - e829
  Abstract: African public health leaders are setting a precedent for productive international health cooperation. The second International Conference for Public Health in Africa on Dec 13–15, 2022, in Kigali, Rwanda, epitomised this power to align the efforts of a rising continent. Africa's highest-level public health conference saw 2500 participants from 90 countries (87% of them from Africa) showcase the richness and confidence of African public health science and practice, with lessons to learn by countries beyond this region.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00171-7
  Issue No: Vol. 11, No. 6 (2023)
[Correspondence] Trans-inclusive HIV services are needed in the
Philippines’ post-pandemic recovery
- Authors: Rowalt Alibudbud
  First page: e830
  Abstract: Before the COVID-19 pandemic, HIV in the Philippines was the fastest-growing epidemic in WHO Western Pacific region.1,2 Although HIV infections remain concentrated among men, HIV infections reported among transgender women doubled during the COVID-19 pandemic. The total HIV infections among this population increased from 714 in 2019 to 1560 in 2022, representing an 118% increase during the pandemic (appendix).3 Transgender women aged 25 to 34 were most affected, accounting for 50% of the total HIV infections, followed by those aged 15–24 years, who account for 28%.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00199-7
  Issue No: Vol. 11, No. 6 (2023)
[Correspondence] Water infrastructure and citizenship exclusion of Roma
communities in Europe
- Authors: Iliana Sarafian
  First page: e831
  Abstract: I commend Joe Brown and colleagues (April, 2023)1 for shedding light on the effects of racism, social exclusion, and discrimination on achieving universal safe water and sanitation in high-income countries. Their example of Roma communities’ access to water and sanitation in France and Italy is particularly poignant. The strong relationship between state power, citizenship, and the ownership and control of water is well established.2 My ethnographic research among Roma communities in Italy3 indicates that the provision of water and sanitation infrastructures is closely linked with social exclusion from citizenship, or, in other words, with what is termed hydraulic citizenship.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00201-2
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Determining the efficiency path to universal health coverage:
cost-effectiveness thresholds for 174 countries based on growth in life
expectancy and health expenditures
- Authors: Andres Pichon-Riviere; Michael Drummond, Alfredo Palacios, Sebastián Garcia-Marti, Federico Augustovski
  Pages: e833 - e842
  Abstract: This approach, based on widely available data, can provide a useful reference for countries using economic evaluations to inform resource-allocation decisions and can enrich international efforts to estimate cost-effectiveness thresholds. Our results show lower thresholds than those currently in use in many countries.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00162-6
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Examining the relationship between armed conflict and coverage
of maternal and child health services in 35 countries in sub-Saharan
Africa: a geospatial analysis
- Authors: Felix Amberg; Collins Chansa, Hamidou Niangaly, Osman Sankoh, Manuela De Allegri
  Pages: e843 - e853
  Abstract: Our findings suggest that health service coverage is significantly affected by contemporaneous conflict, but health systems can adapt to provide routine services, such as child curative services, in situations of prolonged conflict. Our analysis underlines the importance of studying health service coverage during conflict both at the finest possible scales and across different indicators, pointing at the need for differential policy interventions.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00152-3
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Health service quality in 2929 facilities in six low-income and
middle-income countries: a positive deviance analysis
- Authors: Todd P Lewis; Margaret McConnell, Amit Aryal, Grace Irimu, Suresh Mehata, Mwifadhi Mrisho, Margaret E Kruk
  Pages: e862 - e870
  Abstract: Our findings suggest that best-performing health facilities are characterised by good management and leaders who can engage staff and community members. Governments should look to best performers to identify scalable practices and conditions for success that can improve primary care quality overall and decrease quality gaps between health facilities.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00163-8
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Potential impact and cost-effectiveness of Shigella vaccination
in 102 low-income and middle-income countries in children aged 5 years or
younger: a modelling study
- Authors: John D Anderson; Karoun H Bagamian, Clint J Pecenka, Farzana Muhib, Chloe A Puett, William P Hausdorff, Suzanne Scheele
  Pages: e880 - e891
  Abstract: Our model suggests that Shigella vaccination would be a cost-effective intervention, with a substantial impact in specific countries and regions. Other regions could potentially benefit upon the inclusion of the burden of Shigella-related stunting and less severe diarrhoea in the analysis.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00192-4
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Projecting the long-term economic benefits of reducing
Shigella-attributable linear growth faltering with a potential vaccine: a
modelling study
- Authors: Chloe Puett; John D Anderson, Karoun H Bagamian, Farzana Muhib, Suzanne Scheele, William P Hausdorff, Clint Pecenka
  Pages: e892 - e902
  Abstract: LGF is a secondary outcome of Shigella infection and reduction in LGF is not often quantified as a health or economic benefit of vaccination. However, even under conservative assumptions, a Shigella vaccine only moderately effective against LGF could pay for itself from productivity gains alone in some regions. We recommend that LGF be considered in future models assessing the economic and health impacts of interventions preventing enteric infections. Further research is needed on vaccine efficacy against LGF to inform such models.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00050-5
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Diagnostic yield of urine lipoarabinomannan and sputum
tuberculosis tests in people living with HIV: a systematic review and
meta-analysis of individual participant data
- Authors: Tobias Broger; Lisa Koeppel, Helena Huerga, Poppy Miller, Ankur Gupta-Wright, François-Xavier Blanc, Aliasgar Esmail, Byron W P Reeve, Marco Floridia, Andrew D Kerkhoff, Fausto Ciccacci, Margaret P Kasaro, Swe Swe Thit, Mathieu Bastard, Gabriella Ferlazzo, Christina Yoon, Daniël J Van Hoving, Bianca Sossen, Juan Ignacio García, Matthew J Cummings, Rachel M Wake, Josh Hanson, Adithya Cattamanchi, Graeme Meintjes, Gary Maartens, Robin Wood, Grant Theron, Keertan Dheda, Ioana Diana Olaru, Claudia M Denkinger, TBYield Study Consortium
  Pages: e903 - e916
  Abstract: AlereLAM, with its rapid turnaround time and simplicity, should be prioritised to inform tuberculosis therapy among inpatients who are HIV-positive, regardless of symptoms or CD4 cell count. The yield of sputum-based tuberculosis tests is undermined by people living with HIV who cannot produce sputum, whereas nearly all participants are able to provide urine. The strengths of this meta-analysis are its large size, the carefully harmonised denominator, and the use of Bayesian random-effects and mixed-effects models to predict yields; however, data were geographically restricted, clinically diagnosed tuberculosis was not considered in the denominator, and little information exists on strategies for obtaining sputum samples.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00135-3
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Poliovirus antibodies following two rounds of campaigns with a
type 2 novel oral poliovirus vaccine in Liberia: a clustered,
population-based seroprevalence survey
- Authors: Stephen B Kennedy; Grace R Macklin, Gloria Mason Ross, Rocio Lopez Cavestany, Richelot A Moukom, Kathryn A V Jones, Bernardo A Mainou, Moses B F Massaquoi, Mark W S Kieh, Ondrej Mach
  Pages: e917 - e923
  Abstract: Unexpectedly, the data showed low type 2 seroprevalence after two reported doses of nOPV2. This finding is probably affected by the lower oral poliovirus vaccine immunogenicity previously demonstrated in resource-limited settings, with high prevalence of chronic intestinal infections in children and other factors discussed herein. Our results provide the first assessment of nOPV2 performance in outbreak response in the African region.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00116-X
  Issue No: Vol. 11, No. 6 (2023)
[Articles] The impact of ivermectin, diethylcarbamazine citrate, and
albendazole mass drug administration on the prevalence of scabies and
soil-transmitted helminths in school-aged children in three municipalities
in Timor-Leste: a before–after assessment
- Authors: Brandon Le; Merita Antonia Armindo Monteiro, Salvador Amaral, Handan Wand, Alexander Matthews, Sze Fui Hii, Naomi E Clarke, Paul Arkell, Jennifer Yan, Daniel Engelman, Nicholas Fancourt, Jose Liu Fernandes, Andrew Steer, John Kaldor, Rebecca Traub, Joshua R Francis, Susana Vaz Nery
  Pages: e924 - e932
  Abstract: Ivermectin, diethylcarbamazine citrate, and albendazole MDA was associated with substantial reductions in prevalence of scabies, impetigo, and T trichiura, and of moderate-to-heavy intensity A lumbricoides infections. Combination MDA could be used to support integrated control programmes to target multiple NTDs.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00134-1
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Tracking SARS-CoV-2 introductions in Mozambique using
pandemic-scale phylogenies: a retrospective observational study
- Authors: Francisco José Martínez-Martínez; Arsenia J Massinga, Áuria De Jesus, Rita M Ernesto, Pablo Cano-Jiménez, Álvaro Chiner-Oms, Inmaculada Gómez-Navarro, Marina Guillot-Fernández, Caterina Guinovart, António Sitoe, Delfino Vubil, Rubão Bila, Rufino Gujamo, Sónia Enosse, Santiago Jiménez-Serrano, Manuela Torres-Puente, Iñaki Comas, Inácio Mandomando, Mariana G López, Alfredo Mayor
  Pages: e933 - e941
  Abstract: The timing and origin of introductions suggests that movement restrictions effectively avoided introductions from non-African countries, but not from surrounding countries. Our results raise questions about the imbalance between the consequences of restrictions and health benefits. This new understanding of pandemic dynamics in Mozambique can be used to inform public health interventions to control the spread of new variants.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00169-9
  Issue No: Vol. 11, No. 6 (2023)
The global impact of tobacco control policies on smokeless tobacco use: a
systematic review
- Authors: Aastha Chugh; Monika Arora, Neha Jain, Aishwarya Vidyasagaran, Anne Readshaw, Aziz Sheikh, Jappe Eckhardt, Kamran Siddiqi, Mansi Chopra, Masuma Pervin Mishu, Mona Kanaan, Muhammad Aziz Rahman, Ravi Mehrotra, Rumana Huque, Sarah Forberger, Suranji Dahanayake, Zohaib Khan, Melanie Boeckmann, Omara Dogar
  Pages: e953 - e968
  Abstract: Many countries have implemented smokeless tobacco control policies, including those that extend beyond the Framework Convention on Tobacco Control. The available evidence suggests that taxation and multifaceted policy initiatives are associated with meaningful reductions in smokeless tobacco use.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00205-X
  Issue No: Vol. 11, No. 6 (2023)
[Health Policy] Wastewater monitoring can anchor global disease
surveillance systems
- Authors: Aparna Keshaviah; Megan B Diamond, Matthew J Wade, Samuel V Scarpino, Global Wastewater Action Group
  Pages: e976 - e981
  Abstract: To inform the development of global wastewater monitoring systems, we surveyed programmes in 43 countries. Most programmes monitored predominantly urban populations. In high-income countries (HICs), composite sampling at centralised treatment plants was most common, whereas grab sampling from surface waters, open drains, and pit latrines was more typical in low-income and middle-income countries (LMICs). Almost all programmes analysed samples in-country, with an average processing time of 2·3 days in HICs and 4·5 days in LMICs.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-06
  DOI: 10.1016/S2214-109X(23)00170-5
  Issue No: Vol. 11, No. 6 (2023)
[Comment] The importance of quality data to track global progress in
addressing stillbirths and neonatal mortality
- Authors: Sarah Saleem; Elizabeth M McClure
  Pages: e801 - e802
  Abstract: About 2·4 million neonatal deaths1 and 2·0 million stillbirths2 occur each year globally, with 98% of these deaths occurring in low-income and middle-income countries (LMICs). Accurate counting of stillbirth and neonatal deaths is crucial to understanding the true burden of mortality and necessary to understanding countries' progress towards meeting national and international health goals, such as the UN Sustainable Development Goals (SDGs). Only a small fraction of these deaths are registered and the challenges of registering these deaths, including limited resources, cultural considerations, and competing priorities are well documented.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-05-08T22:30:04Z
  DOI: 10.1016/S2214-109X(23)00200-0
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Measuring stillbirth and perinatal mortality rates through
household surveys: a population-based analysis using an integrated
approach to data quality assessment and adjustment with 157 surveys from
53 countries
- Authors: Mohamed M Ali; Saverio Bellizzi, Ties Boerma
  Pages: e854 - e861
  Abstract: A simultaneous focus on stillbirths and early neonatal mortality facilitates a comprehensive assessment of inaccurate reporting in household surveys and allows for better use of surveys in planning and monitoring of efforts to reduce stillbirths and early neonatal mortality.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-05-08T22:30:03Z
  DOI: 10.1016/S2214-109X(23)00125-0
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Incidence and outcomes for stroke in Ulaanbaatar, Mongolia,
during 2019–21: a prospective population-based study
- Authors: Chimeglkham Banzrai; Oyungerel Bosookhuu, Erdenechimeg Yadamsuren, Bolormaa Dambasuren, Sarantsetseg Turbat, Tuguldur Erdenedalai, Mandakhnar Myadagsuren, Uuriintuya Munkhtur, Khandsuren Baatar, Punsaldulam Boldbayar, Tovuudorj Avirmed, Burmaajav Badrakh, Menglu Ouyang, Xiaoying Chen, Xia Wang, Craig S Anderson
  Pages: e942 - e952
  Abstract: The urban population of Ulaanbaatar, Mongolia, has a high incidence of stroke, particularly for intracerebral haemorrhage and subarachnoid haemorrhage, from which half of patients die within 1 month and more than two-thirds are either dead or dependent at 90 days. Although the overall incidence of stroke is similar to other countries, it occurs at a mean age of 60 years, which is at least 10 years younger than in high-income countries. These epidemiological data can inform the implementation of future programmes and scale-up activities for the primary and secondary prevention of stroke, and in the organisation of systems of care.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-04-26T22:30:02Z
  DOI: 10.1016/S2214-109X(23)00130-4
  Issue No: Vol. 11, No. 6 (2023)
[Health Policy] Mental health and psychosocial support in humanitarian
settings: research priorities for 2021–30
- Authors: Wietse A Tol; PhuongThao D Le, Sarah L Harrison, Ananda Galappatti, Jeannie Annan, Florence K Baingana, Theresa S Betancourt, Cecile Bizouerne, Julian Eaton, Michelle Engels, Zeinab Hijazi, Rebecca R Horn, Mark J D Jordans, Brandon A Kohrt, Phiona Koyiet, Catherine Panter-Brick, Michael Pluess, Atif Rahman, Derrick Silove, Mark Tomlinson, José Miguel Uribe-Restrepo, Peter Ventevogel, Inka Weissbecker, Alastair Ager, Mark van Ommeren
  Pages: e969 - e975
  Abstract: We describe an effort to develop a consensus-based research agenda for mental health and psychosocial support (MHPSS) interventions in humanitarian settings for 2021–30. By engaging a broad group of stakeholders, we generated research questions through a qualitative study (in Indonesia, Lebanon, and Uganda; n=101), consultations led by humanitarian agencies (n=259), and an expert panel (n=227; 51% female participants and 49% male participants; 84% of participants based in low-income and middle-income countries).
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-04-25T22:30:02Z
  DOI: 10.1016/S2214-109X(23)00128-6
  Issue No: Vol. 11, No. 6 (2023)
[Articles] Implementation of the 7-1-7 target for detection, notification,
and response to public health threats in five countries: a retrospective,
observational study
- Authors: Aaron F Bochner; Issa Makumbi, Olaolu Aderinola, Aschalew Abayneh, Ralph Jetoh, Rahel L Yemanaberhan, Jenom S Danjuma, Francis T Lazaro, Hani J Mahmoud, Trokon O Yeabah, Lydia Nakiire, Aperki K Yahaya, Renato A Teixeira, Mohammed Lamorde, Immaculate Nabukenya, John Oladejo, Ifedayo M O Adetifa, Wanderson Oliveira, Amanda McClelland, Christopher T Lee
  Pages: e871 - e879
  Abstract: The 7-1-7 target is feasible to measure and to achieve, and assessment with this framework can identify areas for performance improvement and help prioritise national planning. Increased investments must be made at the health facility and intermediate public health levels for improved systems to detect, notify, and rapidly respond to emerging public health threats.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-04-12T22:30:03Z
  DOI: 10.1016/S2214-109X(23)00133-X
  Issue No: Vol. 11, No. 6 (2023)
[Comment] 7-1-7: the promise of tangible results through agility and
accountability
- Authors: Landry Ndriko Mayigane; Liviu Vedrasco, Stella Chungong
  Pages: e805 - e806
  Abstract: In The Lancet Global Health, Aaron F Bochner and colleagues showed how implementing the 7-1-7 target promotes agility and accountability in global health security, using examples from five low-income and middle-income countries.1 The Article emphasises the importance of early action to stem morbidity and save lives, as any delays in detection, notification, and response directly affect the outcome of a public health event.2 Early action also has applications for animal diseases, including zoonoses, where the impact of a disease, if not quickly contained, could decimate entire populations.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-04-12T22:30:02Z
  DOI: 10.1016/S2214-109X(23)00167-5
  Issue No: Vol. 11, No. 6 (2023)
[Corrections] Correction to Lancet Glob Health 2022; 10: e1632–45
- First page: e832
  Abstract: GBD 2019 Indonesia Subnational Collaborators. The state of health in Indonesia's provinces, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Glob Health 2022; 10: e1632–45—For this Article, The GBD 2019 Indonesia Subnational Collaborators list and appendix 2 have been updated. In addition, the appendix page numbers in the main text have been updated. This correction has been made as of April 7, 2023.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-04-07T22:30:01Z
  DOI: 10.1016/S2214-109X(23)00174-2
  Issue No: Vol. 11, No. 6 (2023)
[Comment] Tailoring off-the-shelf global evidence with local
implementation research can boost action on overweight and obesity
- Authors: Angela M Jackson-Morris; Jaime Miranda, Rachel Nugent
  Pages: e826 - e827
  Abstract: Overweight and obesity prevalence among children and adolescents in low-income and middle-income countries (LMICs) rose steeply from 2·5% to 17·3% between 1975 and 2016.1,2 By 2020, 39 million children younger than 5 years and 341·6 million children and adolescents aged 5–19 years were affected. This situation is concerning in terms of the current and future burden of non-communicable diseases in LMICs, because children and adolescents who are overweight or living with obesity are more likely to have high blood pressure, high cholesterol concentrations, type 2 diabetes, asthma, joint problems, gallstones, anxiety, and depression.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-04-06T22:30:01Z
  DOI: 10.1016/S2214-109X(23)00173-0
  Issue No: Vol. 11, No. 6 (2023)
[Comment] Getting health back on the highest political agenda—the UN
High-level Meetings on health in 2023
- Authors: Svetlana Akselrod; Gabriela Cuevas Barron, Katie Dain, Lucica Ditiu, Helga Fogstad, Corine Karema, Justin Koonin, Akihito Watabe
  Pages: e819 - e820
  Abstract: In September, 2023, world leaders will have a unique opportunity to commit to bolstering health systems, to end tuberculosis, and to invigorate progress on health for all, as three United Nations General Assembly (UNGA) High-level Meetings (HLMs) on health will take place back-to-back in New York, USA. The HLMs on pandemic prevention, preparedness, and response (PPR); universal health coverage (UHC); and tuberculosis, on Sept 20–22, can help to place health high on the political agenda. This attention is urgently needed, because most health-related targets in the Sustainable Development Goals (SDGs),1 including those on pandemic PPR, UHC, and tuberculosis, have been thrown off track and inequalities have widened following the COVID-19 pandemic.
  Citation: The Lancet Global Health 11, 6 (2023)
  PubDate: 2023-03-28T22:30:02Z
  DOI: 10.1016/S2214-109X(23)00166-3
  Issue No: Vol. 11, No. 6 (2023)